Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients

Table 2 Clinical characteristics and casual measurements of patients undergoing liver transplantation (LT) pre-treated with propranolol or not

Characteristics and measurements	LT with propranolol (n = 10)	LT without propranolol (n = 11)
Age (yr)	50.6 ± 3.4	50.0 ± 2.6
Sex male/female	3 (30%)/7 (70%)	7 (63.6%)/4 (36.4%)
Child Pugh Score	10.5 ± 0.4	11.2 ± 0.6
MELD Score	28.0 ± 1.1	29.8 ± 1.6
Albumin (g/dL)	2.81 ± 0.09	2.61 ± 0.15
Bilirubin (mg/dL)	3.38 ± 1.20	3.70 ± 0.87
Creatinine (mg/dL)	1.0 (1.0-1.45)	1.05 (0.75-1.50)
INR (International Normalized Ratio)	1.36 (1.32-1.95)	1.69 (1.24-2.11)
Serum Na+ (mEq/L)	135.2 ± 1.0	130.1 ± 1.8a

Data are expressed as mean ± SE or median (25 and 75 percentile), except for sex where number of patients and percentages are shown.

^aP < 0.05 for the comparison of LT with propranolol and LT without propranolol (unpaired t test for mean comparisons and Mann-Whitney test for median comparisons).